Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New drug combo licensed for BPH symptoms

  • Comment

A new drug combination has been licensed in the UK for the treatment of lower urinary tract symptoms in men.

The once-daily fixed-dose combination of solifenacin 6mg/tamsulosin 0.4mg (Vesomni) is licensed for moderate to severe storage symptoms – urgency, increased micturition frequency – and voiding symptoms associated with benign prostatic hyperplasia in men not adequately responding to monotherapy.

It is due to be launched by Astellas Pharma early next year.


  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs